Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16098458

Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Eur J Cancer
Publication date
2005 Aug
First author
Zalcberg JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Zalcberg JR
      type
      Author
    2. name
      Verweij J
      type
      Author
    3. name
      Casali PG
      type
      Author
    4. name
      Le Cesne A
      type
      Author
    5. name
      Reichardt P
      type
      Author
    6. name
      Blay JY
      type
      Author
    7. name
      Schlemmer M
      type
      Author
    8. name
      Van Glabbeke M
      type
      Author
    9. name
      Brown M
      type
      Author
    10. name
      Judson IR
      type
      Author
    11. name
      EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group
      type
      CollectiveName
    12. name
      Australasian Gastrointestinal Trials Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Zalcberg JR
      type
      Author
    2. name
      Verweij J
      type
      Author
    3. name
      Casali PG
      type
      Author
    4. name
      Le Cesne A
      type
      Author
    5. name
      Reichardt P
      type
      Author
    6. name
      Blay JY
      type
      Author
    7. name
      Schlemmer M
      type
      Author
    8. name
      Van Glabbeke M
      type
      Author
    9. name
      Brown M
      type
      Author
    10. name
      Judson IR
      type
      Author
    11. name
      EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group
      type
      CollectiveName
    12. name
      Australasian Gastrointestinal Trials Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-e13df39c2fe111a32bb4295b
    book metadata
    content sha256
    60835cabf18fba1920578b669433c273fbf5ccc50ced3e9b2998b6f0039387ee
    document type
    citation
    dois
    1. 10.1016/j.ejca.2005.04.034
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16098458
    immutable id
    pubmed:16098458@60835cabf18fba1920578b669433c273fbf5ccc50ced3e9b2998b6f0039387ee
    journal
    abbreviation
    Eur J Cancer
    issn electronic
    Source null
    issn print
    0959-8049
    issue
    12
    name
    European journal of cancer (Oxford, England : 1990)
    nlm unique id
    9005373
    pages
    1751-7
    volume
    41
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16098458
      provenance
      batch id
      acd1a19ec1fd03e5b423
      provider
      NCBI PubMed ESummary
      record sha256
      3d3477960ee19620b5cdab0f027ff138b15aa1304382e7c61553186bb5e11682
      response sha256
      06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
      retrieved at
      2026-09-09T23:46:01.895425+00:00
      publication date
      display
      2005 Aug
      precision
      month
      year
      2005
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Journal Article
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16098458/
      title
      Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg.

      Preserved source evidence · Not medical advice